New tool aims to ease egg freezing decisions for taiwanese women
NCT ID NCT07543445
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether a specially designed decision aid can help Taiwanese women who are thinking about freezing their eggs. The goal is to see if the tool improves their knowledge, reduces worry and regret, and helps them make a choice that fits their values. About 120 women will take part, with some using the decision aid and others getting standard advice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 120 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Apr 2026
An estimate. Start dates often move.
- Expected to finish
-
Dec 2031
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
20 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Women aged 20 years or older. * Currently considering elective egg freezing (EEF). * Able to communicate and read Chinese fluently. * Have access to the internet and a mobile device (smartphone, tablet, or computer) to complete online questionnaires. Exclusion Criteria: * Individuals who have previously completed oocyte cryopreservation. * Women undergoing fertility preservation due to malignancy (i.e., breast cancer). * Postmenopausal women.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Assisted reproductive technology are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
National Taiwan University Hospital
Taipei, Taiwan, 100, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a guided AI chatbot help women make better screening decisions?
- Which sperm picking method gives IVF the best shot?
- Can a website teach patients to tame gut pain and skip needless hospital tests?
- Can hormone therapy spare fertility in a challenging endometrial cancer?
- A simple blood test may reveal hidden infertility risk in young cancer survivors
- Could a simple choice sheet curb unneeded opioid prescriptions?